FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


S&P Global Market Intelligence: Delayed Launches, Slow Sales Drive Drugmakers to Adapt Marketing Amid Pandemic

June 15, 2020, 09:10 AM
Filed Under: Pharmaceuticals

According to an article authored by Michael Gibney, Healthcare Reporter, S&P Global Market Intelligence and published by S&P Global Market Intelligence on June 15, 2020, for some biotech and pharmaceutical companies ready to send new drugs out into the world, the coronavirus pandemic has caused a shift in drug launch practices from face-to-face interactions to virtual communication.

To read the full article from S&P Global Market Intelligence, click here.

Week's News

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.